Creo Medical (Creo Medical Group PLC (AIM:CREO)), Chris Hancock (CTO) Cenkos Securities Growth & Innovation Forum on Tuesday 8th February 2022
Creo Medical Group PLC (AIM:CREO) is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. CROMA currently delivers bipolar radiofrequency (RF) energy for precise localised cutting and focused high-frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. The company’s three initial areas of focus are in the GI, soft tissue ablation (including the liver, pancreas and kidney) and lung interventions.
